Ophthalmic Surgery — MCQs

Q: What surgery is used to treat posterior capsular opacification?

Laser Posterior Capsulotomy. **Explanation:** **Posterior Capsular Opacification (PCO)**, often called a "secondary cataract," is the most common late complication of cataract surgery. It occurs due to the proliferation and migration of residual lens epithelial cells across the posterior capsule, leading to decreased visual acuity and glare. **Why Option A is Correct:** The gold standard treatment for PCO is **Nd:YAG Laser Posterior Capsulotomy**. This non-invasive procedure uses a photodisruptive laser to create a small opening in the central axis of the opacified posterior capsule. This clears the visual axis and restores vision without the need for surgical incisions. **Why Other Options are Incorrect:** * **B & C (ECCE and Phacoemulsification):** These are primary surgical techniques used to *remove* a cataractous lens. They are not used to treat complications involving the capsule that remains after the initial surgery. * **D (Lensectomy):** This involves the complete removal of the lens and its capsule (often via the pars plana). It is typically reserved for complex cases like subluxated lenses or pediatric cataracts, not routine PCO. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Signs:** Look for **Elschnig pearls** (vacuolated cells) or **Soemmering’s ring** on slit-lamp examination. * **Laser Type:** Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet) is a **solid-state, pulsed** laser. * **Mechanism:** It works via **photodisruption** (plasma formation). * **Complications of YAG Capsulotomy:** The most common high-yield complication is a transient **rise in Intraocular Pressure (IOP)**. Other risks include cystoid macular edema (CME) and retinal detachment.

Q: Examination of the vitreous is best performed by which of the following methods?

Indirect ophthalmoscope. **Explanation:** The examination of the vitreous requires a technique that provides a wide field of view, excellent illumination, and stereopsis (depth perception) to visualize the transparent gel and any associated pathologies. **Why Indirect Ophthalmoscopy is the Correct Answer:** The **Indirect Ophthalmoscope** is the gold standard for a comprehensive evaluation of the vitreous cavity. It utilizes a strong light source and a condensing lens (typically 20D) to provide a **wide-angled, stereoscopic, and bright image**. This allows the examiner to visualize the vitreous from the anterior hyaloid face all the way to the peripheral retina (ora serrata), making it superior for detecting vitreous opacities, hemorrhages, or membranes. **Analysis of Incorrect Options:** * **A. Direct Ophthalmoscope:** While it provides high magnification, it lacks stereopsis and has a very narrow field of view (about 5-10 degrees), making it ineffective for surveying the three-dimensional vitreous volume. * **C. Slit-lamp with a contact lens:** While a slit-lamp with a Hruby lens or a Goldmann 3-mirror lens provides excellent detail of the posterior vitreous and vitreoretinal interface, the **Indirect Ophthalmoscope** remains the primary and best method for a global, comprehensive examination of the entire vitreous body. * **D. Oblique illumination:** This is a basic technique used primarily for the anterior segment (cornea, iris, lens) and cannot penetrate or visualize the vitreous cavity effectively. **High-Yield Clinical Pearls for NEET-PG:** * **Shafer’s Sign:** The presence of "tobacco dust" (RPE cells) in the anterior vitreous on slit-lamp exam is a pathognomonic sign of a retinal tear. * **Weiss Ring:** A ring-shaped opacity in the vitreous indicating a posterior vitreous detachment (PVD). * For the **extreme periphery** of the vitreous/retina, indirect ophthalmoscopy combined with **scleral indentation** is the technique of choice.

Q: In recurrent chalazion, histopathological examination is done to rule out which of the following?

Sebaceous cell carcinoma. **Explanation:** **1. Why Sebaceous Cell Carcinoma is correct:** A chalazion is a chronic granulomatous inflammation of the **Meibomian glands** (which are modified sebaceous glands). **Sebaceous Cell Carcinoma (SGC)** is a highly malignant tumor that most commonly arises from these same glands. SGC is notorious for being a "masquerade syndrome"; it often presents clinically as a painless, firm nodule, mimicking a chalazion. Therefore, in cases of **recurrent chalazion** at the same site or a chalazion with atypical features (e.g., loss of lashes, irregular consistency) in elderly patients, a biopsy is mandatory to rule out SGC. **2. Why the other options are incorrect:** * **Squamous Cell Carcinoma (SCC):** While SCC is a common eyelid malignancy, it typically arises from the surface epithelium (keratinocytes) and presents as an ulcerated plaque or nodule, rather than mimicking an internal glandular blockage like a chalazion. * **Adenoid Cystic Carcinoma:** This is a rare, aggressive tumor usually associated with the lacrimal gland, not the Meibomian glands. * **Adenoma Carcinoma:** This is not a standard clinical term for eyelid malignancies; sebaceous adenoma is a benign precursor, but the primary concern in recurrence is the malignant carcinoma. **Clinical Pearls for NEET-PG:** * **Masquerade Syndrome:** SGC can also mimic chronic blepharoconjunctivitis (pagetoid spread). * **Most Common Site:** Unlike Basal Cell Carcinoma (which favors the lower lid), SGC is more common in the **upper lid** because Meibomian glands are more numerous there. * **Staining:** SGC stains positive with **Oil Red O** or **Sudan IV** (requires fresh frozen tissue). * **Management of Chalazion:** Initial treatment is warm compresses; if it fails, Incision and Curettage (I&C) is done via a **vertical incision** (to avoid damaging adjacent Meibomian glands).

Q: Triple surgery in glaucoma includes all of the following except?

Insertion of drainage device. **Explanation:** The term **"Triple Procedure"** in ophthalmology refers to a combined surgical approach performed in a single sitting to manage patients who have both a significant cataract and glaucoma. The primary goal is to restore vision while simultaneously controlling intraocular pressure (IOP). **Why Option C is the correct answer:** A "Triple Procedure" specifically consists of three distinct steps: **Cataract extraction + Intraocular lens (IOL) implantation + Trabeculectomy.** The insertion of a glaucoma drainage device (like an Ahmed Glaucoma Valve) is a separate surgical intervention used for refractory glaucoma and is not considered a component of the standard "triple surgery" definition. **Analysis of Incorrect Options:** * **Option A (Trabeculectomy):** This is the filtering component of the triple procedure, providing a new drainage pathway for aqueous humor to lower IOP. * **Option B (PCIOL implantation):** Posterior Chamber Intraocular Lens (PCIOL) implantation is the refractive component, replacing the natural lens to restore clear vision. * **Option D (Extra capsular cataract extraction):** This is the cataract removal component. While modern surgeons often use Phacoemulsification (Phaco-triple), the classic definition includes any form of extracapsular extraction (ECCE). **High-Yield Clinical Pearls for NEET-PG:** * **Phaco-triple:** The most common modern variation involving Phacoemulsification + PCIOL + Trabeculectomy. * **Indications:** Indicated when a patient has a clinically significant cataract and glaucoma that is poorly controlled on maximal medical therapy. * **Advantage:** Reduces the risk of postoperative IOP spikes that often occur after standalone cataract surgery in glaucoma patients. * **Site:** Often performed through two separate incisions (superior for trabeculectomy and temporal for phacoemulsification) to improve the success rate of the bleb.

Q: Following enucleation of a painful blind eye, when is an appropriately sized artificial prosthesis typically fitted post-operatively?

About 10 days. **Explanation:** The goal of post-enucleation management is to maintain the volume of the orbit and ensure a good cosmetic result. The process occurs in two distinct stages: 1. **Immediate Post-op (Conformer):** At the end of the surgery, a clear plastic **conformer** is placed in the conjunctival fornices. This prevents the socket from shrinking and maintains the shape of the fornices while the wound heals. 2. **Fitting the Prosthesis (The Correct Answer):** An artificial prosthesis (the "glass eye") is typically fitted **about 10 days** (range 10–14 days) after the surgery. By this time, the initial inflammatory edema has subsided, and the conjunctival incision has healed sufficiently to support the weight and movement of a temporary or custom prosthesis. **Analysis of Incorrect Options:** * **B (20 days):** While not harmful, waiting 20 days is unnecessarily long. Early fitting (around day 10) is preferred to ensure the patient’s psychological rehabilitation and to prevent any early contraction of the socket. * **C & D (6–24 weeks):** These timeframes are far too late. Delaying the prosthesis for months can lead to **socket contraction** (symblepharon formation), making it difficult or impossible to fit a prosthesis later without further reconstructive surgery. **High-Yield Clinical Pearls for NEET-PG:** * **Enucleation vs. Evisceration:** Enucleation involves removing the entire eyeball with a portion of the optic nerve. Evisceration involves removing the intraocular contents while leaving the sclera and extraocular muscles intact. * **Indications for Enucleation:** Painful blind eye (most common), intraocular malignancies (e.g., Retinoblastoma), and to prevent **Sympathetic Ophthalmitis** after penetrating trauma. * **Implant vs. Prosthesis:** An *implant* (e.g., hydroxyapatite) is placed deep in the orbit during surgery; the *prosthesis* is the removable shell fitted over it at 10 days.

Q: In Dacryocystorhinostomy, into which anatomical structure is the opening made?

Middle meatus. **Explanation:** **Dacryocystorhinostomy (DCR)** is a surgical procedure performed to bypass an obstructed nasolacrimal duct by creating a direct communication between the lacrimal sac and the nasal cavity. **Why Middle Meatus is Correct:** The lacrimal sac lies in the lacrimal fossa, which is anatomically separated from the nasal cavity by the lacrimal bone and the frontal process of the maxilla. This fossa corresponds internally to the lateral wall of the nose, specifically **anterior to the middle turbinate in the middle meatus**. During DCR, an osteotomy (bone window) is created at this site to allow tears to drain directly from the sac into the middle meatus, bypassing the distal obstruction. **Why Other Options are Incorrect:** * **Superior Meatus:** This is located high in the nasal cavity, above the middle turbinate. It primarily receives drainage from the posterior ethmoidal air cells and the sphenoid sinus (via the sphenoethmoidal recess). It is anatomically too high and posterior for DCR. * **Inferior Meatus:** This is the physiological drainage site of the **nasolacrimal duct** (guarded by the Valve of Hasner). In DCR, we are creating a *new* opening because the natural pathway to the inferior meatus is blocked. **High-Yield Clinical Pearls for NEET-PG:** * **Success Rate:** DCR has a high success rate (>90%) for post-saccular obstructions. * **Key Landmark:** The **Middle Turbinate** is the most important surgical landmark during Endoscopic DCR. * **Contraindication:** DCR should not be performed if there is a suspicion of a lacrimal sac tumor or in cases of atrophic rhinitis. * **Jones Tubes:** Used in Conjunctivodacryocystorhinostomy (CDCR) when the canaliculi are also obstructed.

Q: Which agent is used to prevent synechiae after dacryocystorhinostomy (DCR) surgery?

Mitomycin. **Explanation:** **Mitomycin C (MMC)** is a potent alkylating agent that inhibits fibroblast proliferation and collagen synthesis. In Dacryocystorhinostomy (DCR), the most common cause of surgical failure is the formation of fibrous tissue and **synechiae** (adhesions) at the osteotomy site or within the nasal ostium, which leads to secondary closure. Intraoperative application of MMC (typically 0.2–0.5 mg/ml for 2–5 minutes) to the osteotomy site significantly reduces scarring, maintains patency, and improves the success rate of the procedure. **Analysis of Incorrect Options:** * **Tacrolimus:** A calcineurin inhibitor used primarily for its immunosuppressive properties in preventing organ transplant rejection or treating severe vernal keratoconjunctivitis (VKC). It does not have a primary role in preventing post-surgical synechiae in DCR. * **Cyclosporine:** Similar to Tacrolimus, this is an immunomodulator used in dry eye disease (Restasis) and corneal graft rejection. It lacks the potent anti-fibrotic effect required to prevent ostium closure. * **Doxycycline:** A tetracycline antibiotic with some anti-matrix metalloproteinase (MMP) activity. While used in ocular rosacea and meibomian gland dysfunction, it is not used to prevent surgical adhesions in lacrimal surgery. **High-Yield Clinical Pearls for NEET-PG:** * **MMC in Ophthalmology:** Apart from DCR, MMC is high-yield for its use in **Glaucoma filtration surgery (Trabeculectomy)** to prevent bleb fibrosis and in **Pterygium surgery** to prevent recurrence. * **DCR Success:** The most critical step in DCR is the creation of a large osteotomy and the precise apposition of mucosal flaps. * **Contraindication:** MMC should be used with caution as it can cause delayed wound healing or mucosal atrophy if used in excessive concentrations.

Q: In a chalazion with multiple recurrences at the same site, what is the recommended management instead of incision and curettage?

Excision biopsy. **Explanation:** The primary concern in a **recurrent chalazion at the same site**, especially in elderly patients, is the possibility of a masked malignancy. The most common mimic is **Sebaceous Gland Carcinoma (Meibomian Gland Carcinoma)**, which can clinically present as a painless, firm nodule identical to a chalazion. Therefore, the standard of care shifts from simple drainage to an **excision biopsy** to rule out malignancy through histopathological examination. **Analysis of Options:** * **D. Excision Biopsy (Correct):** This is mandatory for recurrent lesions to differentiate a benign chalazion from Sebaceous Gland Carcinoma. The specimen must be sent for histopathology (often requiring special stains like Oil Red O if the tissue is fresh). * **A. Cauterisation with carbolic acid:** This is an outdated method used to destroy the cyst wall but does not provide a tissue diagnosis, making it dangerous if a malignancy is present. * **B. Cryotherapy:** While used for certain lid tumors (like Basal Cell Carcinoma), it is not the primary diagnostic or therapeutic step for a recurrent chalazion. * **C. Intralesional Triamcinolone:** This is an alternative treatment for *non-recurrent* chalazia (especially those near the lacrimal punctum to avoid surgical trauma). However, it is contraindicated in recurrent cases as it may delay the diagnosis of a tumor. **Clinical Pearls for NEET-PG:** * **Chalazion** is a chronic non-infectious granulomatous inflammation of the **Meibomian glands** (Type IV hypersensitivity). * **Sebaceous Gland Carcinoma** is known as the "Great Masquerader" because it mimics chalazion or chronic blepharoconjunctivitis. * If a chalazion is associated with loss of eyelashes (**madarosis**) or thickening of the lid margin (tylosis), suspicion of malignancy should be very high. * The surgical incision for a chalazion is **vertical** (on the conjunctival surface) to avoid damaging adjacent Meibomian glands.

Q: What is the wavelength of a YAG laser?

Colorless. The **Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet)** laser is a solid-state laser widely used in ophthalmology. Its fundamental wavelength is **1064 nm**, which falls within the **Infrared (IR)** spectrum. Because the infrared spectrum is outside the range of human visibility (which is roughly 400 nm to 700 nm), the laser beam itself is **colorless** or invisible to the naked eye. ### Why the other options are incorrect: * **Red:** Lasers in the red spectrum (e.g., Krypton Red at 647 nm or Diode lasers at 670–810 nm) are visible. While some Diode lasers approach the infrared range, they are distinct from the 1064 nm YAG. * **Green:** The Frequency-doubled Nd:YAG (KTP laser) produces a wavelength of **532 nm**, which is green. This is used for retinal photocoagulation, unlike the standard 1064 nm YAG. * **Blue:** Argon lasers can produce blue-green light (488–514 nm). These are visible and used for different therapeutic purposes. ### NEET-PG High-Yield Clinical Pearls: * **Mechanism of Action:** The Nd:YAG laser works via **Photodisruption** (ionizing tissue to create plasma/shockwaves), unlike the Argon laser which works via *Photocoagulation*. * **Clinical Uses:** Its primary uses are **Posterior Capsulotomy** (for PCO/After-cataract) and **Peripheral Iridotomy** (for Angle-Closure Glaucoma). * **Safety Feature:** Since the 1064 nm beam is invisible, manufacturers incorporate a low-energy **Red He-Ne (Helium-Neon) aiming beam** so the surgeon can see where the laser is focused. * **Mode:** It is typically used in **Q-switched** mode to deliver high energy in ultrashort bursts (nanoseconds).

Ophthalmic Surgery Indian Medical PG Practice Questions and MCQs

Question 1: What surgery is used to treat posterior capsular opacification?

A. Laser Posterior Capsulotomy (Correct Answer)
B. Extracapsular cataract Extraction
C. Phacoemulsification
D. Lensectomy

Explanation: **Explanation:** **Posterior Capsular Opacification (PCO)**, often called a "secondary cataract," is the most common late complication of cataract surgery. It occurs due to the proliferation and migration of residual lens epithelial cells across the posterior capsule, leading to decreased visual acuity and glare. **Why Option A is Correct:** The gold standard treatment for PCO is **Nd:YAG Laser Posterior Capsulotomy**. This non-invasive procedure uses a photodisruptive laser to create a small opening in the central axis of the opacified posterior capsule. This clears the visual axis and restores vision without the need for surgical incisions. **Why Other Options are Incorrect:** * **B & C (ECCE and Phacoemulsification):** These are primary surgical techniques used to *remove* a cataractous lens. They are not used to treat complications involving the capsule that remains after the initial surgery. * **D (Lensectomy):** This involves the complete removal of the lens and its capsule (often via the pars plana). It is typically reserved for complex cases like subluxated lenses or pediatric cataracts, not routine PCO. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Signs:** Look for **Elschnig pearls** (vacuolated cells) or **Soemmering’s ring** on slit-lamp examination. * **Laser Type:** Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet) is a **solid-state, pulsed** laser. * **Mechanism:** It works via **photodisruption** (plasma formation). * **Complications of YAG Capsulotomy:** The most common high-yield complication is a transient **rise in Intraocular Pressure (IOP)**. Other risks include cystoid macular edema (CME) and retinal detachment.

Question 2: Examination of the vitreous is best performed by which of the following methods?

A. Direct ophthalmoscope
B. Indirect ophthalmoscope (Correct Answer)
C. Slit-lamp with a contact lens
D. Oblique illumination

Explanation: **Explanation:** The examination of the vitreous requires a technique that provides a wide field of view, excellent illumination, and stereopsis (depth perception) to visualize the transparent gel and any associated pathologies. **Why Indirect Ophthalmoscopy is the Correct Answer:** The **Indirect Ophthalmoscope** is the gold standard for a comprehensive evaluation of the vitreous cavity. It utilizes a strong light source and a condensing lens (typically 20D) to provide a **wide-angled, stereoscopic, and bright image**. This allows the examiner to visualize the vitreous from the anterior hyaloid face all the way to the peripheral retina (ora serrata), making it superior for detecting vitreous opacities, hemorrhages, or membranes. **Analysis of Incorrect Options:** * **A. Direct Ophthalmoscope:** While it provides high magnification, it lacks stereopsis and has a very narrow field of view (about 5-10 degrees), making it ineffective for surveying the three-dimensional vitreous volume. * **C. Slit-lamp with a contact lens:** While a slit-lamp with a Hruby lens or a Goldmann 3-mirror lens provides excellent detail of the posterior vitreous and vitreoretinal interface, the **Indirect Ophthalmoscope** remains the primary and best method for a global, comprehensive examination of the entire vitreous body. * **D. Oblique illumination:** This is a basic technique used primarily for the anterior segment (cornea, iris, lens) and cannot penetrate or visualize the vitreous cavity effectively. **High-Yield Clinical Pearls for NEET-PG:** * **Shafer’s Sign:** The presence of "tobacco dust" (RPE cells) in the anterior vitreous on slit-lamp exam is a pathognomonic sign of a retinal tear. * **Weiss Ring:** A ring-shaped opacity in the vitreous indicating a posterior vitreous detachment (PVD). * For the **extreme periphery** of the vitreous/retina, indirect ophthalmoscopy combined with **scleral indentation** is the technique of choice.

Question 3: Contracted socket occurs because of all the following except?

A. Chronic low-grade infection
B. Chronic mechanical irritation
C. Irradiation
D. Loss of orbital fatty tissue during enucleation (Correct Answer)

Explanation: ### Explanation A **contracted socket** is a condition where the orbital cavity shrinks, leading to a reduction in the surface area of the conjunctival fornices. This makes it difficult or impossible to retain a prosthetic eye. **1. Why "Loss of orbital fatty tissue" is the correct answer:** Loss of orbital fat during enucleation leads to **Enophthalmos** (a sunken appearance) and a "deep superior sulcus" deformity, but it does **not** cause a contracted socket. While the volume of the orbit is reduced, the mucosal lining (conjunctiva) remains intact. A contracted socket is primarily a failure of the **conjunctival surface area**, not just a loss of posterior orbital volume. **2. Analysis of Incorrect Options:** * **Chronic low-grade infection:** Persistent inflammation (e.g., chronic discharge) leads to sub-conjunctival fibrosis and scarring, which gradually pulls the fornices inward, causing contraction. * **Chronic mechanical irritation:** An ill-fitting prosthesis or a rough-surfaced artificial eye acts as a chronic irritant, triggering a cicatricial (scarring) response in the conjunctiva. * **Irradiation:** Radiotherapy for orbital tumors (like Retinoblastoma) causes endarteritis obliterans and tissue ischemia, leading to severe fibrosis and shrinkage of the socket tissues. **3. Clinical Pearls for NEET-PG:** * **Definition:** A contracted socket is characterized by the shortening of the conjunctival fornices (especially the inferior fornix). * **Commonest Cause:** The most common cause is the **non-wearing of a prosthesis** for a long duration after surgery, leading to disuse atrophy of the fornices. * **Management:** * *Mild:* Conformers or mucous membrane grafts. * *Severe:* Reconstruction using a split-thickness skin graft or amniotic membrane transplant. * **Distinction:** Do not confuse **Post-Enucleation Socket Syndrome (PESS)**—which includes fat atrophy and ptosis—with a **Contracted Socket**, which specifically refers to mucosal scarring.

Question 4: In recurrent chalazion, histopathological examination is done to rule out which of the following?

A. Squamous cell Carcinoma
B. Adenoid cystic carcinoma
C. Sebaceous cell carcinoma (Correct Answer)
D. Adenoma carcinoma

Explanation: **Explanation:** **1. Why Sebaceous Cell Carcinoma is correct:** A chalazion is a chronic granulomatous inflammation of the **Meibomian glands** (which are modified sebaceous glands). **Sebaceous Cell Carcinoma (SGC)** is a highly malignant tumor that most commonly arises from these same glands. SGC is notorious for being a "masquerade syndrome"; it often presents clinically as a painless, firm nodule, mimicking a chalazion. Therefore, in cases of **recurrent chalazion** at the same site or a chalazion with atypical features (e.g., loss of lashes, irregular consistency) in elderly patients, a biopsy is mandatory to rule out SGC. **2. Why the other options are incorrect:** * **Squamous Cell Carcinoma (SCC):** While SCC is a common eyelid malignancy, it typically arises from the surface epithelium (keratinocytes) and presents as an ulcerated plaque or nodule, rather than mimicking an internal glandular blockage like a chalazion. * **Adenoid Cystic Carcinoma:** This is a rare, aggressive tumor usually associated with the lacrimal gland, not the Meibomian glands. * **Adenoma Carcinoma:** This is not a standard clinical term for eyelid malignancies; sebaceous adenoma is a benign precursor, but the primary concern in recurrence is the malignant carcinoma. **Clinical Pearls for NEET-PG:** * **Masquerade Syndrome:** SGC can also mimic chronic blepharoconjunctivitis (pagetoid spread). * **Most Common Site:** Unlike Basal Cell Carcinoma (which favors the lower lid), SGC is more common in the **upper lid** because Meibomian glands are more numerous there. * **Staining:** SGC stains positive with **Oil Red O** or **Sudan IV** (requires fresh frozen tissue). * **Management of Chalazion:** Initial treatment is warm compresses; if it fails, Incision and Curettage (I&C) is done via a **vertical incision** (to avoid damaging adjacent Meibomian glands).

Question 5: Triple surgery in glaucoma includes all of the following except?

A. Trabeculectomy
B. PCIOL implantation
C. Insertion of drainage device (Correct Answer)
D. Extra capsular cataract extraction

Explanation: **Explanation:** The term **"Triple Procedure"** in ophthalmology refers to a combined surgical approach performed in a single sitting to manage patients who have both a significant cataract and glaucoma. The primary goal is to restore vision while simultaneously controlling intraocular pressure (IOP). **Why Option C is the correct answer:** A "Triple Procedure" specifically consists of three distinct steps: **Cataract extraction + Intraocular lens (IOL) implantation + Trabeculectomy.** The insertion of a glaucoma drainage device (like an Ahmed Glaucoma Valve) is a separate surgical intervention used for refractory glaucoma and is not considered a component of the standard "triple surgery" definition. **Analysis of Incorrect Options:** * **Option A (Trabeculectomy):** This is the filtering component of the triple procedure, providing a new drainage pathway for aqueous humor to lower IOP. * **Option B (PCIOL implantation):** Posterior Chamber Intraocular Lens (PCIOL) implantation is the refractive component, replacing the natural lens to restore clear vision. * **Option D (Extra capsular cataract extraction):** This is the cataract removal component. While modern surgeons often use Phacoemulsification (Phaco-triple), the classic definition includes any form of extracapsular extraction (ECCE). **High-Yield Clinical Pearls for NEET-PG:** * **Phaco-triple:** The most common modern variation involving Phacoemulsification + PCIOL + Trabeculectomy. * **Indications:** Indicated when a patient has a clinically significant cataract and glaucoma that is poorly controlled on maximal medical therapy. * **Advantage:** Reduces the risk of postoperative IOP spikes that often occur after standalone cataract surgery in glaucoma patients. * **Site:** Often performed through two separate incisions (superior for trabeculectomy and temporal for phacoemulsification) to improve the success rate of the bleb.

Question 6: Following enucleation of a painful blind eye, when is an appropriately sized artificial prosthesis typically fitted post-operatively?

A. About 10 days (Correct Answer)
B. About 20 days
C. 6-8 weeks
D. 12-24 weeks

Explanation: **Explanation:** The goal of post-enucleation management is to maintain the volume of the orbit and ensure a good cosmetic result. The process occurs in two distinct stages: 1. **Immediate Post-op (Conformer):** At the end of the surgery, a clear plastic **conformer** is placed in the conjunctival fornices. This prevents the socket from shrinking and maintains the shape of the fornices while the wound heals. 2. **Fitting the Prosthesis (The Correct Answer):** An artificial prosthesis (the "glass eye") is typically fitted **about 10 days** (range 10–14 days) after the surgery. By this time, the initial inflammatory edema has subsided, and the conjunctival incision has healed sufficiently to support the weight and movement of a temporary or custom prosthesis. **Analysis of Incorrect Options:** * **B (20 days):** While not harmful, waiting 20 days is unnecessarily long. Early fitting (around day 10) is preferred to ensure the patient’s psychological rehabilitation and to prevent any early contraction of the socket. * **C & D (6–24 weeks):** These timeframes are far too late. Delaying the prosthesis for months can lead to **socket contraction** (symblepharon formation), making it difficult or impossible to fit a prosthesis later without further reconstructive surgery. **High-Yield Clinical Pearls for NEET-PG:** * **Enucleation vs. Evisceration:** Enucleation involves removing the entire eyeball with a portion of the optic nerve. Evisceration involves removing the intraocular contents while leaving the sclera and extraocular muscles intact. * **Indications for Enucleation:** Painful blind eye (most common), intraocular malignancies (e.g., Retinoblastoma), and to prevent **Sympathetic Ophthalmitis** after penetrating trauma. * **Implant vs. Prosthesis:** An *implant* (e.g., hydroxyapatite) is placed deep in the orbit during surgery; the *prosthesis* is the removable shell fitted over it at 10 days.

Question 7: In Dacryocystorhinostomy, into which anatomical structure is the opening made?

A. Superior meatus
B. Middle meatus (Correct Answer)
C. Inferior meatus
D. None of the above

Explanation: **Explanation:** **Dacryocystorhinostomy (DCR)** is a surgical procedure performed to bypass an obstructed nasolacrimal duct by creating a direct communication between the lacrimal sac and the nasal cavity. **Why Middle Meatus is Correct:** The lacrimal sac lies in the lacrimal fossa, which is anatomically separated from the nasal cavity by the lacrimal bone and the frontal process of the maxilla. This fossa corresponds internally to the lateral wall of the nose, specifically **anterior to the middle turbinate in the middle meatus**. During DCR, an osteotomy (bone window) is created at this site to allow tears to drain directly from the sac into the middle meatus, bypassing the distal obstruction. **Why Other Options are Incorrect:** * **Superior Meatus:** This is located high in the nasal cavity, above the middle turbinate. It primarily receives drainage from the posterior ethmoidal air cells and the sphenoid sinus (via the sphenoethmoidal recess). It is anatomically too high and posterior for DCR. * **Inferior Meatus:** This is the physiological drainage site of the **nasolacrimal duct** (guarded by the Valve of Hasner). In DCR, we are creating a *new* opening because the natural pathway to the inferior meatus is blocked. **High-Yield Clinical Pearls for NEET-PG:** * **Success Rate:** DCR has a high success rate (>90%) for post-saccular obstructions. * **Key Landmark:** The **Middle Turbinate** is the most important surgical landmark during Endoscopic DCR. * **Contraindication:** DCR should not be performed if there is a suspicion of a lacrimal sac tumor or in cases of atrophic rhinitis. * **Jones Tubes:** Used in Conjunctivodacryocystorhinostomy (CDCR) when the canaliculi are also obstructed.

Question 8: Which agent is used to prevent synechiae after dacryocystorhinostomy (DCR) surgery?

A. Mitomycin (Correct Answer)
B. Tacrolimus
C. Cyclosporine
D. Doxycycline

Explanation: **Explanation:** **Mitomycin C (MMC)** is a potent alkylating agent that inhibits fibroblast proliferation and collagen synthesis. In Dacryocystorhinostomy (DCR), the most common cause of surgical failure is the formation of fibrous tissue and **synechiae** (adhesions) at the osteotomy site or within the nasal ostium, which leads to secondary closure. Intraoperative application of MMC (typically 0.2–0.5 mg/ml for 2–5 minutes) to the osteotomy site significantly reduces scarring, maintains patency, and improves the success rate of the procedure. **Analysis of Incorrect Options:** * **Tacrolimus:** A calcineurin inhibitor used primarily for its immunosuppressive properties in preventing organ transplant rejection or treating severe vernal keratoconjunctivitis (VKC). It does not have a primary role in preventing post-surgical synechiae in DCR. * **Cyclosporine:** Similar to Tacrolimus, this is an immunomodulator used in dry eye disease (Restasis) and corneal graft rejection. It lacks the potent anti-fibrotic effect required to prevent ostium closure. * **Doxycycline:** A tetracycline antibiotic with some anti-matrix metalloproteinase (MMP) activity. While used in ocular rosacea and meibomian gland dysfunction, it is not used to prevent surgical adhesions in lacrimal surgery. **High-Yield Clinical Pearls for NEET-PG:** * **MMC in Ophthalmology:** Apart from DCR, MMC is high-yield for its use in **Glaucoma filtration surgery (Trabeculectomy)** to prevent bleb fibrosis and in **Pterygium surgery** to prevent recurrence. * **DCR Success:** The most critical step in DCR is the creation of a large osteotomy and the precise apposition of mucosal flaps. * **Contraindication:** MMC should be used with caution as it can cause delayed wound healing or mucosal atrophy if used in excessive concentrations.

Question 9: In a chalazion with multiple recurrences at the same site, what is the recommended management instead of incision and curettage?

A. Cauterisation with carbolic acid
B. Cryotherapy
C. Intralesional injection of triamcinolone
D. Excision biopsy (Correct Answer)

Explanation: **Explanation:** The primary concern in a **recurrent chalazion at the same site**, especially in elderly patients, is the possibility of a masked malignancy. The most common mimic is **Sebaceous Gland Carcinoma (Meibomian Gland Carcinoma)**, which can clinically present as a painless, firm nodule identical to a chalazion. Therefore, the standard of care shifts from simple drainage to an **excision biopsy** to rule out malignancy through histopathological examination. **Analysis of Options:** * **D. Excision Biopsy (Correct):** This is mandatory for recurrent lesions to differentiate a benign chalazion from Sebaceous Gland Carcinoma. The specimen must be sent for histopathology (often requiring special stains like Oil Red O if the tissue is fresh). * **A. Cauterisation with carbolic acid:** This is an outdated method used to destroy the cyst wall but does not provide a tissue diagnosis, making it dangerous if a malignancy is present. * **B. Cryotherapy:** While used for certain lid tumors (like Basal Cell Carcinoma), it is not the primary diagnostic or therapeutic step for a recurrent chalazion. * **C. Intralesional Triamcinolone:** This is an alternative treatment for *non-recurrent* chalazia (especially those near the lacrimal punctum to avoid surgical trauma). However, it is contraindicated in recurrent cases as it may delay the diagnosis of a tumor. **Clinical Pearls for NEET-PG:** * **Chalazion** is a chronic non-infectious granulomatous inflammation of the **Meibomian glands** (Type IV hypersensitivity). * **Sebaceous Gland Carcinoma** is known as the "Great Masquerader" because it mimics chalazion or chronic blepharoconjunctivitis. * If a chalazion is associated with loss of eyelashes (**madarosis**) or thickening of the lid margin (tylosis), suspicion of malignancy should be very high. * The surgical incision for a chalazion is **vertical** (on the conjunctival surface) to avoid damaging adjacent Meibomian glands.

Question 10: What is the wavelength of a YAG laser?

A. Colorless (Correct Answer)
B. Red
C. Green
D. Blue

Explanation: The **Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet)** laser is a solid-state laser widely used in ophthalmology. Its fundamental wavelength is **1064 nm**, which falls within the **Infrared (IR)** spectrum. Because the infrared spectrum is outside the range of human visibility (which is roughly 400 nm to 700 nm), the laser beam itself is **colorless** or invisible to the naked eye. ### Why the other options are incorrect: * **Red:** Lasers in the red spectrum (e.g., Krypton Red at 647 nm or Diode lasers at 670–810 nm) are visible. While some Diode lasers approach the infrared range, they are distinct from the 1064 nm YAG. * **Green:** The Frequency-doubled Nd:YAG (KTP laser) produces a wavelength of **532 nm**, which is green. This is used for retinal photocoagulation, unlike the standard 1064 nm YAG. * **Blue:** Argon lasers can produce blue-green light (488–514 nm). These are visible and used for different therapeutic purposes. ### NEET-PG High-Yield Clinical Pearls: * **Mechanism of Action:** The Nd:YAG laser works via **Photodisruption** (ionizing tissue to create plasma/shockwaves), unlike the Argon laser which works via *Photocoagulation*. * **Clinical Uses:** Its primary uses are **Posterior Capsulotomy** (for PCO/After-cataract) and **Peripheral Iridotomy** (for Angle-Closure Glaucoma). * **Safety Feature:** Since the 1064 nm beam is invisible, manufacturers incorporate a low-energy **Red He-Ne (Helium-Neon) aiming beam** so the surgeon can see where the laser is focused. * **Mode:** It is typically used in **Q-switched** mode to deliver high energy in ultrashort bursts (nanoseconds).

Practice by Chapter

Surgical Anatomy of Eye

Practice Questions

Asepsis and Sterilization in Eye Surgery

Practice Questions

Anesthesia in Ophthalmic Surgery

Practice Questions

Cataract Surgery Techniques

Practice Questions

Corneal Surgeries

Practice Questions

Glaucoma Surgeries

Practice Questions

Oculoplastic Surgeries

Practice Questions

Vitreoretinal Surgeries

Practice Questions

Strabismus Surgery

Practice Questions

Refractive Surgery

Practice Questions

Ocular Oncology Surgeries

Practice Questions

Management of Surgical Complications

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free